Co-Diagnostics Inc (NASDAQ:CODX) will be hosting a booth at the upcoming India Diagnostic Expo with its joint venture partner CoSara Diagnostics Pvt Ltd to formally launch their recently approved in vitro diagnostics (IVDs) tests.
The India Diagnostic Expo, to be held January 4-6 in Hyderabad, India, provides the country’s only diagnostics products and consumables exhibition for the diagnostic services market.
Co-Diagnostics, based in Salt Lake City, Utah, said that the market is expected to continue growing at 27.5% during the next five years.
The company’s attendance at the expo follows the announcement last month that the Central Drug Standard Control Organization, India’s regulatory body, approved JV partner CoSara’s tests for tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (HPV).
The licenses and regulatory clearance granted by the regulatory agency allows the five tests to be manufactured and sold for the detection of the respective diseases, with the expo marking their first formal launch in the Indian market.
“We are pleased to officially launch these newly approved diagnostics tests into India,” Co-Diagnostics CEO Dwight Egan said in a statement on Thursday.
“We believe that our patented technology and proprietary design process gives products designed on the CoPrimer platform a competitive edge in such a large and growing market, and the company looks forward to a successful roll-out of these in-demand diagnostics.”
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham